ON THE MECHANISM OF EFFICACY OF URSODEOXYCHOLIC ACID IN CHRONIC HEPATITIS C
The investigation of the molecular components of the mechanism of action of Ursofalk® during antiviral therapy for chronic hepatitis C has demonstrated its involvement of many intermolecular interactions, which makes it possible to continue a search for new target molecules to design agents for the treatment of hepatitis C.